Sage Journals: Discover world-class research

Abstract

Background:

Insulin pump failures had been assessed in our center by a prospective observational study from 2001 to 2007. The aim of this study was to update our data since 2008 and to determine whether there exist specific risk factors for insulin pump failures.

Methods:

All insulin pump defects were prospectively collected between 2008 and 2013 in a monocentric cohort of 350 new pumps. Clinical consequences were recorded. Brand and model of pumps and type of defects and patients' characteristics (gender, type of diabetes, age at diabetes diagnosis, age at first pump, pump treatment duration, number of previous pumps, and number of previous pump failures) were tested for possible association with insulin pump failure.

Results:

Malfunctions occurred in 239 (68%) pumps. The incidence rate was 33/100 pump-years. There were 28 (12%) complete failures, 17 (7%) alarms, 83 (35%) mechanical defects, and 105 (44%) minor defects. Survival curves did not differ according to pump brand and model. Hyperglycemia occurred in 2.9% of cases. In multivariate analysis, only patient age less than 40 years at the initiation of pump therapy was associated with higher risk of malfunction (hazard ratio 1.64; 95% confidence interval 1.19–2.24; P = 0.002).

Conclusions:

Pump malfunctions remain common with modern pumps. We report less complete failures than in our previous study. This could be because of improvement in quality of pumps or to our strategy of systematic screening and replacement in case of mechanical defects.

Get full access to this article

View all access options for this article.

References

Pickup

, Keen

, Parsons

, et al.: Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J, 1978; 1:204–207.

Misso

, Egberts

, Page

, et al.: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev, 2010:CD005103.

Pozzilli

, Battelino

, Danne

, et al.: Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev, 2016; 32:21–39.

Giani

, Scaramuzza

, Zuccotti

: Impact of new technologies on diabetes care. World J Diabetes, 2015; 6:999–1004.

Guilhem

, Leguerrier

, Lecordier

, et al.: Technical risks with subcutaneous insulin infusion. Diabetes Metab, 2006; 32:279–284.

Cope

, Morrison

, Samuels-Reid

: Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events. Pediatrics, 2008; 121:e1133–e1138.

Heinemann

, Fleming

, Petrie

, et al.: Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia, 2015; 58:862–870.

Guilhem

, Balkau

, Lecordier

, et al.: Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007. Diabetologia, 2009; 52:2662–2664.

Wheeler

, Heels

, Donaghue

, et al.: Insulin pump-associated adverse events in children and adolescents—a prospective study. Diabetes Technol Ther, 2014; 16:558–562.

10.

Scaramuzza

, Dell'Acqua

, Macedoni

, et al.: Insulin pump therapy in children with type 1 diabetes: the dark side of the moon. J Diabetes Sci Technol, 2013; 7:1095–1097.

11.

Pickup

, Yemane

, Brackenridge

, et al.: Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diabetes Technol Ther, 2014; 16:145–149.

12.

Ross

, Milburn

, Reith

, et al.: Clinical review: insulin pump-associated adverse events in adults and children. Acta Diabetol, 2015; 52:1017–1024.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB